← Leaderboards
Khalid Benamar
Temple Univ Of The Commonwealth
$3,625,175
Attributed
$4,401,025
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $742.2K · FY2010–24$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,401,025 · 8
By mechanism
R21$2,390,408 · 5
R01$1,551,700 · 1
R03$458,917 · 2
Top collaborators
- Mary E Abood5 shared
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Scott M Rawls$11,077,907
- Xiao-Feng Yang$16,352,501
Others in their field
Top investigators on “Analgesics”
- Richard T D'aquila · Massachusetts General Hospital$27,454,413
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$25,078,909
- David J Julius · University Of California, San Francisco$24,283,903
- Sandra D. Comer · New York State Psychiatric Institute$21,433,459
- Lynn Kirkpatrick · Ensysce Biosciences, Inc.$20,649,999
- Maurizio Fava · Massachusetts General Hospital$19,316,294
Research focus
AnalgesicsPainResponsePain ManagementAreaAgonistPainful NeuropathyReceptorHiv-1SensoryBrainPharmaceutical PreparationsCannabinoidsBaseChronicInterdisciplinary ApproachAntiretroviral TherapyChronic PainMaleAffectFemaleMental DepressionHypersensitivityMidbrain Central Gray Substance
Grant awards (20)
EcoHIV and neuropathic pain$185,000
R21 · FY2024 · NS · contact PI
HIV-1 and Alzheimerâs disease: Comorbidity$407,000
R21 · FY2023 · AG · contact PI
EcoHIV and neuropathic pain$222,000
R21 · FY2023 · NS · contact PI
Endocannabinoid system and HIV-related neuropathic pain$501,177
R21 · FY2022 · DA · contact PI
Beta-caryophyllene (BCP) and cannabidiol (CBD) combination: HIV-1 chronic neuropathic pain$173,780
R21 · FY2022 · DA · contact PI
Alzheimerâs disease and chronic pain$47,326
R21 · FY2022 · DA · contact PI
Beta-caryophyllene (BCP) and cannabidiol (CBD) combination: HIV-1 chronic neuropathic pain$11,600
R21 · FY2022 · DA · contact PI
Endocannabinoid system and HIV-related neuropathic pain$8,315
R21 · FY2022 · DA · contact PI
Beta-caryophyllene (BCP) and cannabidiol (CBD) combination: HIV-1 chronic neuropathic pain$229,500
R21 · FY2021 · DA · contact PI
Endocannabinoid system and HIV-related neuropathic pain$229,500
R21 · FY2021 · DA · contact PI
Beta-caryophyllene and cannabidiol combination: Chronic arthritis pain$153,000
R03 · FY2020 · NS · contact PI
Functional Role for GPR55 in the periaqueductal gray$312,000
R01 · FY2018 · DA
Functional Role for GPR55 in the periaqueductal gray$312,000
R01 · FY2017 · DA
Functional Role for GPR55 in the periaqueductal gray$308,880
R01 · FY2016 · DA
Functional Role for GPR55 in the periaqueductal gray$307,320
R01 · FY2015 · DA
Functional Role for GPR55 in the periaqueductal gray$311,500
R01 · FY2014 · DA
Chemokine Antagonist, Opioid Medication and HIV gp120$153,000
R03 · FY2012 · DA · contact PI
Gp120 in the brain and opioid medications: Functional interactions$185,210
R21 · FY2011 · DA · contact PI
Chemokine Antagonist, Opioid Medication and HIV gp120$152,917
R03 · FY2011 · DA · contact PI
Gp120 in the brain and opioid medications: Functional interactions$190,000
R21 · FY2010 · DA · contact PI